Viemed Healthcare (NASDAQ:VMD – Get Free Report) posted its earnings results on Wednesday. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01), FiscalAI reports. The company had revenue of $80.67 million for the quarter, compared to analyst estimates of $80.78 million. Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%.
Viemed Healthcare Price Performance
Shares of Viemed Healthcare stock traded up $0.66 on Wednesday, reaching $10.11. The company’s stock had a trading volume of 235,161 shares, compared to its average volume of 284,677. The company has a market capitalization of $385.09 million, a P/E ratio of 28.08, a PEG ratio of 2.28 and a beta of 1.05. Viemed Healthcare has a 52-week low of $6.05 and a 52-week high of $12.61. The stock has a 50-day moving average price of $9.24 and a 200-day moving average price of $9.56. The company has a quick ratio of 1.02, a current ratio of 1.13 and a debt-to-equity ratio of 0.04.
Analysts Set New Price Targets
Several equities research analysts have commented on VMD shares. Weiss Ratings lowered Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, August 17th. Barrington Research assumed coverage on shares of Viemed Healthcare in a report on Monday, August 24th. They set an “outperform” rating and a $14.00 target price for the company. Wall Street Zen cut shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. Finally, Freedom Capital lowered shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 5th. One analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Viemed Healthcare presently has an average rating of “Hold” and a consensus target price of $14.00.
Read Our Latest Stock Report on Viemed Healthcare
About Viemed Healthcare
Viemed Healthcare, Inc (NASDAQ: VMD) is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.
The company’s offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.
Read More
- Five stocks we like better than Viemed Healthcare
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
